ÇÐʵ°ü¹ÜCGD»¼ÕßÓÃÒ© Èøü¶à¡°ÓÐÊý²¡¡±»¼Õß±»Íû¼û
¿ËÈÕ£¬£¬£¬£¬£¬£¬£¬¹ú¼ÒÎÀ½¡Î¯¡¢¿Æ¼¼²¿¡¢¹¤ÒµºÍÐÅÏ¢»¯²¿¡¢¹ú¼ÒÒ©¼à¾ÖµÈÁù²¿·ÖÍŽáÐû²¼ÁË¡¶µÚ¶þÅúÓÐÊý²¡Ä¿Â¼¡·£¬£¬£¬£¬£¬£¬£¬°üÀ¨Èí¹Ç·¢Óý²»È«¡¢Ö«¶Ë·Ê´óÖ¢¡¢½ºÖÊĸϸ°ûÁö¡¢ÐþÉ«ËØÁöµÈ86ÖÖÓÐÊý²¡¡£¡£¡£¡£¡£¡£¡£ÕâÒ»ÐÅÏ¢µÄÐû²¼£¬£¬£¬£¬£¬£¬£¬ÈÃÓÐÊý²¡¼°ÓÐÊý²¡ÈËȺÔÙ´ÎÒýÆðÉç»áÆÕ±é¹Ø×¢¡£¡£¡£¡£¡£¡£¡£
×÷ÉõÓÐÊý²¡£¡£¡£¡£¡£¡£¡£¿£¿£¿£¿£¿¡¶ÖйúÓÐÊý²¡½ç˵Ñо¿±¨¸æ2021¡·½«ÐÂÉú¶ù·¢²¡ÂÊСÓÚ1/Íò¡¢»¼²¡ÂÊСÓÚ1/Íò¡¢»¼²¡ÈËÊýСÓÚ14ÍòµÄ¼²²¡»®ÈëÓÐÊý²¡¡£¡£¡£¡£¡£¡£¡£¿ÉÊÇ£¬£¬£¬£¬£¬£¬£¬ÄãÖªµÀÂ𣿣¿£¿£¿£¿ÓÐÒ»ÖÖºÜÊÇÓÐÊýµÄ¼²²¡½ÐÂýÐÔÈâÑ¿Öײ¡£¡£¡£¡£¡£¡£¡£¨CGD£©£¬£¬£¬£¬£¬£¬£¬ËüÔÚÃÀ¹úµÄ·¢²¡ÂÊԼΪ1/200000£¬£¬£¬£¬£¬£¬£¬ÆäËû¹ú¼ÒΪ1/450000¡«1/111000[1]£¬£¬£¬£¬£¬£¬£¬ÎÒ¹úËäÔÝʱûÓÐÏà¹ØÊ¢Ðв¡Ñ§Êý¾Ý£¬£¬£¬£¬£¬£¬£¬¾ÝÏÖÔÚÎÄÏ×±¨µÀµÄº£ÄÚÀúÄêÀۼƲ¡Àý½öÊý°ÙÀý¡£¡£¡£¡£¡£¡£¡£
ÈË×ÌÈÅËØ¦Ã£¨IFN¦Ã£©ÖÎÁÆCGD»¼¶ù»ñÒæÏÔ×Å
ÂýÐÔÈâÑ¿Öײ¡£¡£¡£¡£¡£¡£¡£¨CGD£©ÊÇÒ»ÖÖÓÐÊýµÄÔ·¢ÐÔÃâÒßȱÏݲ¡£¬£¬£¬£¬£¬£¬£¬ÔÚÓ¤¶ùÆÚ»òÓ×¶ùÆÚ·¢²¡£¬£¬£¬£¬£¬£¬£¬Ö÷ÒªÌØÕ÷ÎªÖØ¸´ÇÒÑÏÖØµÄϸ¾úºÍÕæ¾úѬȾ¼°ÈâÑ¿Ö×Ðγɣ¬£¬£¬£¬£¬£¬£¬×îµä·¶µÄÁÙ´²ÌåÏÖÓÐÖØ¸´·¢ÈÈ¡¢¾Ö²¿»¯Å§ÐÔÑ×Ö¢£¨°üÀ¨Öظ´·Î²¿Ñ¬È¾¡¢ÁÜͶºÏÑס¢¸ÎŧÖס¢¹ÇËèÑס¢Æ¤·ôŧÖ×»ò·äÎÑÖ¯Ñ×£©£¬£¬£¬£¬£¬£¬£¬ÖØÕßΣ¼°ÉúÃü¡£¡£¡£¡£¡£¡£¡£
CGDµÄÖÎÁÆÄѶȽϴ󣬣¬£¬£¬£¬£¬£¬´ËǰÖ÷Òª½ÓÄɰüÀ¨¿¹ÉúËØ¡¢¿¹Õæ¾ú¡¢¿¹½áºËÒ©ÎïµÄ¶ÔÖ¢ÖÎÁÆ£¬£¬£¬£¬£¬£¬£¬µ«ÎÞ·¨¶Ô¸Ã¼²²¡¾ÙÐÐÓÅÒìÖÎÀí£¬£¬£¬£¬£¬£¬£¬Òò´Ë±£´æÉÐδ֪×ãµÄÁÙ´²ÐèÇ󡣡£¡£¡£¡£¡£¡£
È»¶ø£¬£¬£¬£¬£¬£¬£¬ÓÐÒ»ÖÖÒ©Æ·£¬£¬£¬£¬£¬£¬£¬ÎªCGD»¼¶ù´øÀ´ÁËеÄÏ£Íû£¡2022Ä꣬£¬£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©¼¯ÍÅ×ÔÖ÷Ñз¢¼°Éú²úµÄ¡°×¢ÉäÓÃÈË×ÌÈÅËØ¦Ã¡±£¨ÉÌÆ·Ãû£º¿Ë¡٤Âê?£¬£¬£¬£¬£¬£¬£¬¼ò³ÆIFN¦Ã£©CGD˳Ӧ֢»ñÅúÉÏÊУ¬£¬£¬£¬£¬£¬£¬Îªº£ÄÚ¶À¼ÒÉÏÊеÄCGDÃâÒßÖÎÁÆÒ©Îï¡£¡£¡£¡£¡£¡£¡£
¡°×îÔçÎÒÃÇÕâ¿îÒ©Ö÷ÒªÓÃÓÚÀà·çʪÐÔÊàŦÑ׺͸ÎÏËά»¯Ë³Ó¦Ö¢µÄÖÎÁÆ£¬£¬£¬£¬£¬£¬£¬¼ÇµÃ2018ÄÇÄêIFN¦ÃÔøÓйýÒ»¶Îʱ¼äÍ£²ú¡£¡£¡£¡£¡£¡£¡£Ê±´úÎÒÃǽӵ½²»ÉÙ»¼Õß¾ìÊô¡¢Ò½ÔºµÄµç»°Ñ¯ÎÊ£¬£¬£¬£¬£¬£¬£¬ÐÄÇéÊ®·Ö½¹ÂÇ£¬£¬£¬£¬£¬£¬£¬ØÊºó²ÅÖªµÀÕâ¸öÒ©Æ·ÔÚÁÙ´²ÉÏ»¹ÓÃÓÚÏÈÌìÐÔÃâÒßȱÏݲ¡ÂýÐÔÈâÑ¿Ö×£¨CGD£©ºÍÃϵ¶ûÒÅ´«·ÖÖ¦¸Ë¾úÒ׸в¡£¡£¡£¡£¡£¡£¡£¨MSMD£©µÈÓÐÊý²¡µÄÖÎÁÆ£¬£¬£¬£¬£¬£¬£¬¶ÔÓÐЩº¢×ÓÀ´ËµÈ·ÊµÊǾÈÃüÒ©¡£¡£¡£¡£¡£¡£¡£¡±¸ÃÒ©ÎïÉú²úÆóÒµÈÏÕæÈ˿ïÉúÎï×Ü˾Àí´÷ËØÏ¼ÏÈÈÝ˵¡£¡£¡£¡£¡£¡£¡£
2019Ä꣬£¬£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©ÔÚ»ñÖªÉÏÊöÐÅÏ¢ºó£¬£¬£¬£¬£¬£¬£¬Ñ¸ËÙÓëÁÙ´²×¨¼ÒÈ¡µÃÁËÁªÏµ£¬£¬£¬£¬£¬£¬£¬¾ÍIFN¦ÃÄ¿½ñÔÚÓÐÊý²¡ÖÎÁÆÁìÓòµÄÓ¦ÓÃÇéÐξÙÐÐÁËÏàͬ½»Á÷¡£¡£¡£¡£¡£¡£¡£ÏÖÔÚ£¬£¬£¬£¬£¬£¬£¬Ôڸü²²¡Ñо¿ÁìÓò£¬£¬£¬£¬£¬£¬£¬ÉϺ£¸´µ©´óѧÁ¥Êô¶ù¿ÆÒ½Ôº×ßÔÚǰÏߣ¬£¬£¬£¬£¬£¬£¬¸ÃÔºÁÙ´²ÃâÒ߿ƵÄÍõÏþ´¨½ÌÊÚÍŶÓÍŽáÍâÑóÏȽøÂÄÀú£¬£¬£¬£¬£¬£¬£¬Õë¶ÔCGD»¼¶ùÔ·¢ÐÔÃâÒßȱÏݵļ²²¡Ìص㣬£¬£¬£¬£¬£¬£¬ÔÚ¿¹Ñ¬È¾¶ÔÖ¢ÖÎÁƵĻù´¡ÉÏ£¬£¬£¬£¬£¬£¬£¬Ì½Ë÷ÐÔÌí¼ÓIFN¦ÃÖÎÁÆ¡£¡£¡£¡£¡£¡£¡£ÁÙ´²Êµ¼ù֤ʵ£¬£¬£¬£¬£¬£¬£¬IFN¦ÃÔÚCGDÖеÄÓ¦ÓÿÉÒÔÏÔןÄÉÆ»¼¶ùµÄÉúÑÄ״̬£¬£¬£¬£¬£¬£¬£¬½µµÍÑÏÖØÑ¬È¾µÄ±¬·¢Âʺͱ¬·¢Æµ´Î£¬£¬£¬£¬£¬£¬£¬½µµÍÖÂËÀÂÊ£¬£¬£¬£¬£¬£¬£¬Ìá¸ßÉúÑÄÖÊÁ¿£¬£¬£¬£¬£¬£¬£¬¾ßÓÐÏÔ×ŵÄÁÙ´²»ñÒæ[2£¬£¬£¬£¬£¬£¬£¬3]¡£¡£¡£¡£¡£¡£¡£
¼á³ÖÉú²ú °ü¹Ü»¼ÕßÓÐÒ©¿ÉÓÃ
Ëæ×ÅÊÖÒÕµÄǰ½ø£¬£¬£¬£¬£¬£¬£¬ ËäÈ»CGDÄ¿½ñΨһÖÎÓúÁÆ·¨ÎªÔìѪ¸Éϸ°ûÒÆÖ²£¬£¬£¬£¬£¬£¬£¬µ«²¢·ÇËùÓл¼Õß¾ùÇкÏÒÆÖ²Ìõ¼þ¡¢»òÅäÐÍÎÞ·¨Àֳɡ¢»òÓÉÓÚÓöȸ߰º¶øÎÞ·¨ÔâÊÜ¡¢ÒÔ¼°Ë¼Á¿ÊõºóÒÆÖ²ÎËÞÖ÷·´Ó¦Î£º¦µÈ¶àÖÖÎÊÌ⣬£¬£¬£¬£¬£¬£¬²¿·Ö»¼ÕßÎÞ·¨½ÓÊÜÒÆÖ²ÊÖÊõ£¬£¬£¬£¬£¬£¬£¬ÐèÒªºã¾Ã´ø²¡ÉúÑÄ¡£¡£¡£¡£¡£¡£¡£ÕâЩ»¼¶ùÐèÒªºã¾ÃʹÓÃIFN¦Ã¾ÙÐÐÖÎÁÆ¡£¡£¡£¡£¡£¡£¡£
±ðµÄ£¬£¬£¬£¬£¬£¬£¬¹ØÓÚ½ÓÊÜÔìѪ¸Éϸ°ûÒÆÖ²µÄ»¼Õߣ¬£¬£¬£¬£¬£¬£¬ÊÖÊõ֮ǰ±ØÐèά³Ö¼²²¡Îȹ̣¬£¬£¬£¬£¬£¬£¬¶ø¿ØÖÆÑ¬È¾ÊǺÜÊÇÒªº¦µÄÒòËØ£¬£¬£¬£¬£¬£¬£¬Òò´Ë£¬£¬£¬£¬£¬£¬£¬ÔÚÒÆÖ²ÆÚ´ýÆÚµÄ»¼Õßͨ³£Ê¹ÓÃIFN¦ÃÒÔÓÐÓÿØÖÆÑ¬È¾¡£¡£¡£¡£¡£¡£¡£
ÕýÓÉÓÚ¡°ÓÐÊý¡±ÐÔ£¬£¬£¬£¬£¬£¬£¬ÓÐÊý²¡ÓÃÒ©µÄÊг¡ÐèÇóÁ¿Ò²ºÜÊÇÓÐÏÞ£¬£¬£¬£¬£¬£¬£¬»¼ÕߵĺϼÆÄêÓÃÁ¿½ÏÉÙ£¬£¬£¬£¬£¬£¬£¬¶øÒ©³§Éú²ú¸ÃҩÿÅúÖÆ¼Á×îµÍÅúÁ¿Í¨³£Îª¼¸ÍòÖ§£¬£¬£¬£¬£¬£¬£¬Éú²ú±¾Ç®½Ï¸ß£¬£¬£¬£¬£¬£¬£¬ÇÒÿÉú²úÒ»Åú£¬£¬£¬£¬£¬£¬£¬ÒòÏúÁ¿¼«ÆäÓÐÏÞ£¬£¬£¬£¬£¬£¬£¬´ó²¿·Ö²úÆ·¿ÉÄܽ«±¨·Ï¡£¡£¡£¡£¡£¡£¡£¿£¿£¿£¿£¿Ã¯ÉúÎï×Ü˾Àí´÷ËØÏ¼ÌåÏÖ£¬£¬£¬£¬£¬£¬£¬¡°ÔÚÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©¼¯ÍŵÄÖ§³ÖÏ£¬£¬£¬£¬£¬£¬£¬ÒÔÈËÐÔÖ÷Òå¾ÈÖÎΪĿµÄ£¬£¬£¬£¬£¬£¬£¬´ÓÉç»áÔðÈγö·¢£¬£¬£¬£¬£¬£¬£¬×ÝÈ»Õâ¸öÒ©´¦ÓÚ¡°Éú²ú¼´¿÷Ë𡱵Ä״̬£¬£¬£¬£¬£¬£¬£¬ÆóÒµ¾öÒéδÀ´¼á³ÖÉú²úÏÂÈ¥£¬£¬£¬£¬£¬£¬£¬ÒÔ×ÊÖú¼õÇá¸ü¶à»¼¶ùµÄ¼²²¡Í´¿à£¬£¬£¬£¬£¬£¬£¬½µµÍÖÂËÀÂÊ£¬£¬£¬£¬£¬£¬£¬Îª»¼¶ù¼ÒÍ¥´øÀ´ºã¾ÃÎÞ²¡ÉúÑĵÄÏ£Íû¡£¡£¡£¡£¡£¡£¡£¡±
²Î¿¼ÎÄÏ×£º
1.½¯ÀûƼ?µÈ£¬£¬£¬£¬£¬£¬£¬ÂýÐÔÈâÑ¿Öײ¡Ñо¿Ï£Íû£¬£¬£¬£¬£¬£¬£¬¡¶ÊÊÓöù¿ÆÁÙ´²ÔÓÖ¾¡·£¬£¬£¬£¬£¬£¬£¬2012£¬£¬£¬£¬£¬£¬£¬27£¨21£©£º1628-1630
2¡¢»ÝÏþÓ¨µÈ£¬£¬£¬£¬£¬£¬£¬ÂýÐÔÈâÑ¿Öײ¡ÖÐÔ¶ÆÚËæ·ÃºÍѬȾԤ·ÀÐÔÒ©ÎïµÄЧ¹ûÆÊÎö£¬£¬£¬£¬£¬£¬£¬¡¶ÖйúÑÖ¤¶ù¿ÆÔÓÖ¾¡·£¬£¬£¬£¬£¬£¬£¬2012£¬£¬£¬£¬£¬£¬£¬7£¨5£©£º321-325
3¡¢Qinhua Zhou, et. al., A cohort of 169 chronic granulomatous disease patients exposed to GCG vaccination: a retrospective study from a single center in Shanghai, China (2004-2017), Journal of Clinical Immunology, 2018, 38:260-272
ÑÓÉêÔĶÁ£ºÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©ÓëÓÐÊý²¡
ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©Ê¼ÖÕ½«Á¢ÒìÊÓΪÆóÒµ¿ÉÒ»Á¬Éú³¤×îÖ÷ÒªµÄÉç»áÔðÈΣ¬£¬£¬£¬£¬£¬£¬ÖÂÁ¦ÓÚÌáÉý²úÆ·¿É¼°ÐԺͿɼ縺ÐÔ¡£¡£¡£¡£¡£¡£¡£ÔÚÓÐÊý²¡ÁìÓò£¬£¬£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©¼¯ÍÅʼÖÕÆð¾¢ÏìÓ¦¹ú¼Ò¶¦Á¦´ó¾ÙÌᳫÁÙ´²¼±ÐèºÍÓÐÊý²¡Ò©ÎïµÄ×¢²áÑз¢¡£¡£¡£¡£¡£¡£¡£×èÖ¹2023Äê6ÔÂÄ©£¬£¬£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©ÒѾÉÏÊÐÁ½¿îÓÐÊý²¡»ò¹Â¶ùÒ©²úÆ·ËÕ¿ÉÐÀ£¨ÂíÀ´Ëá°¢·¥Çú²´ÅÁƬ£©ºÍά¸ñ¶¨£¨°±¼ºÏ©Ëá¿Ú·þÈÜÒºÓÃÉ¢£©£¬£¬£¬£¬£¬£¬£¬²¢Ò»Á¬ÍƽøÓÐÊý²¡²úÆ·Ïß½¨É裬£¬£¬£¬£¬£¬£¬Í¨¹ýÁ¢ÒìÑз¢¹Ø°®ÓÐÊý²¡ÈºÌ壬£¬£¬£¬£¬£¬£¬ÖÂÁ¦ÓÚÌá¸ßÁ¢ÒìÖÎÁÆÒ©ÎïÔÚÓÐÊý²¡»¼ÕßÖеĿɼ°ÐÔ¡£¡£¡£¡£¡£¡£¡£
2019Äê9Ô£¬£¬£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©¼ÓÈëÖйúÓÐÊý²¡Í¬ÃË¡£¡£¡£¡£¡£¡£¡£¸ÃͬÃËÓɱ±¾©ÐºÍÒ½Ôº¡¢ÖйúÒ½Ò©Á¢ÒìÔö½ø»á¡¢ÖйúҽԺлáµÈǣͷÌᳫ£¬£¬£¬£¬£¬£¬£¬Ö¼ÔÚÍÆ¶¯Ò½Ñ§ÔÚÓÐÊý²¡Ñо¿·½ÃæÈ¡µÃÖØ´óÍ»ÆÆ£¬£¬£¬£¬£¬£¬£¬ÌáÉýÓÐÊý²¡·ÀÖÎÓë°ü¹Üˮƽ£¬£¬£¬£¬£¬£¬£¬Ôö½øÓÐÊý²¡ÁÙ´²¡¢¿ÆÑÐÓë¹Â¶ùÒ©¿ª·¢µÄÐͬÁ¢Òì¡£¡£¡£¡£¡£¡£¡£
2020Äê12ÔÂ23ÈÕ£¬£¬£¬£¬£¬£¬£¬ÔÚÉϺ£ÊÐÓÅÉúÓÅÓý¿ÆÑ§Ð»á£¨ÉϺ£Êи¾Ó×±£½¡Ð»á£©¡¢ÉϺ£ÊÐÓÐÊý²¡·ÀÖλù½ð»á¡¢ÉϺ£¸ßˮƽµØ·½¸ßÐ£ÖØµãÁ¢ÒìÍŶӣ¨¶ùͯ¿µ½¡Î¬»¤ÓëÔö½ø£©ÏîĿר¼Ò×éµÄÖ¸µ¼Ï£¬£¬£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©Ð¯ÊÖÉϺ£ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾¹«Òæ»ù½ð»á¡¢¸´µ©´óѧÁ¥Êô¶ù¿ÆÒ½Ôº£¬£¬£¬£¬£¬£¬£¬ÅäºÏÆô¶¯¡°ÐÇÑ¿¡±¶ùͯÓÐÊý²¡¹Ø°®Ðж¯¡£¡£¡£¡£¡£¡£¡£ÏÖÔÚ£¬£¬£¬£¬£¬£¬£¬¸ÃÏîÄ¿ÒÑÀۼƾÈÖú29ÃûÍâÊ¡ÊÐÀ´»¦ÖÎÁƵľ¼ÃÄÑÌâµÄÓÐÊý²¡»¼¶ù£¬£¬£¬£¬£¬£¬£¬ÁýÕÖÊ®ÓàÖÖÓÐÊý²¡£¬£¬£¬£¬£¬£¬£¬°üÀ¨ÂýÐÔÈâÑ¿Öס¢¿ËÂÞ¶÷²¡¡¢±´ºÕÇÐÌØ×ÛºÏÖ¢µÈ¡£¡£¡£¡£¡£¡£¡£





